SUBSCribe
logo
twitterlinkedininstagramUser Profile
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
          • LEADING EDGE
          • SMART ENTERPRISE
        • Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?

          Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh

          V Keshavdev - December 10, 2020
        • How KKR India reached a debt end

          The marquee private equity firm’s strategy of lending to growth companies and risky turnarounds has backfired badly, denting its reputation as a savvy financier

          Krishna Gopalan - January 24, 2020

        Latest Edition

        magcover
        March 12, 2021
        magcover
        February 26, 2021
        magcover
        February 12, 2021
        magcover
        January 29, 2021
        twitterlinkedininstagramUser Profile
        • BIG STORY
        • PERSPECTIVE
        • ENTERPRISE
        • STRATEGY
        • MARKETS
        • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C'EST LA VIE
        • MAGAZINE
        About us Contact usPrivacy PolicyTerms and ConditionsSitemap
        Copyright © 2019 Outlook Business!. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.